Talphera (TLPH) EBT Margin Growth (5y) (2016 - 2025)
Powered by 
Analysis
Talphera (TLPH) EBT Margin Growth (5y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -33.34 Mn |
| Mar 31, 2025 | -620,040.00 |
| Dec 31, 2023 | 44,363.00 |
| Sep 30, 2023 | 209,425.00 |
| Jun 30, 2023 | -46,063.00 |
| Mar 31, 2022 | -161,451.00 |
| Dec 31, 2021 | -39.57 Mn |
| Sep 30, 2021 | -10,998.00 |
| Jun 30, 2021 | -197,777.00 |
| Mar 31, 2021 | -154,273.00 |
| Dec 31, 2020 | -59,811.00 |
| Sep 30, 2020 | -69,064.00 |
| Jun 30, 2020 | 23,658.00 |
| Mar 31, 2020 | 119,519.00 |
| Dec 31, 2019 | 307,774.00 |
| Sep 30, 2019 | -210,782.00 |
| Jun 30, 2019 | 1.59 Mn |
| Mar 31, 2019 | 443,694.00 |
| Dec 31, 2018 | -206,029.00 |
| Sep 30, 2018 | -178,809.00 |